JDD Buzz Series | Dietary Strategies in Psoriasis Management
Dermatology clinicians have a plethora of treatment options to consider for their psoriasis patients, from topicals to phototherapy to systemics. Yet there’s a non-prescription, adjunctive strategy that clinicians may hesitate to broach in office visits for psoriasis. Research shows dietary strategies that reduce energy intake, such as a low-calorie diet or intermittent fasting, may reduce psori …
Dermatology clinicians have a plethora of treatment options to consider for their psoriasis patients, from topicals to phototherapy to systemics. Yet there’s a non-prescription, adjunctive strategy that clinicians may hesitate to broach in office visits for psoriasis. Research shows dietary strategies that reduce energy intake, such as a low-calorie diet or intermittent fasting, may reduce psori … Continue reading "JDD Buzz Series | Dietary Strategies in Psoriasis Management"
Roflumilast is a non-steroidal topical cream that was FDA approved for the treatment of plaque psoriasis in 2022.1 Roflumilast selectively inhibits phosphodiesterase-4 (PDE-4), which is an enzyme that mediates inflammatory responses and has been shown to play a role in several dermatologic diseases.2 Prior to topical roflumilast, oral PDE-4 inhibitors have been investigated across a wide variety o … 
As part of the recent 2020 Integrative Dermatology Symposium, Dr. Jason Hawkes, Associate Clinical Professor of Dermatology at UC Davis, provided a fantastically comprehensive primer on the management of psoriasis in the COVID-19 era. Read on for important treatment recommendations and insights to improve your clinical practice!
As an introduction, Dr. Hawkes emphasized that psoriasis remains a …